What does cheek filler do, and how is it placed?
Cheek filler replaces some of the support the midface loses with age, usually by placing a firm gel deep, near the cheekbone. Two hyaluronic acid fillers carry an FDA indication for cheek volume, and in their trials most treated people still showed improvement a year later. The change is often modest, and the cheek has arteries that make anatomy, depth and a careful injector matter.
What midface volume loss is
The cheek is held up by layers: bone, deep fat pads, ligaments that tether them, muscle, and skin. A review of facial overfilling describes facial ageing as a combination of collagen and elastin loss in the skin, weaker supporting ligaments, sagging fat pads and bone resorption. In the midface that shows as a flatter cheek, a deeper shadow between the lower lid and the cheek, and a heavier fold from the nose to the mouth corner.
Cheek filler addresses one part of that picture. It puts back some of the volume and structural support the midface has lost, usually by placing a firm gel deep, near the cheekbone. It does not tighten skin and it does not reverse the other changes.
What cheek filler can and cannot change
Restoring support in the upper cheek can change how the areas around it look. The fold beside the mouth may soften because the tissue above it is held a little higher. In the Voluma XC trial, which injected only the midface, in the Voluma XC trial, 57% (236 of 414) of treatment group assessments at month 6 showed at least a one-point improvement in the nasolabial folds, which were not injected (source, verified ). That is a real effect, and it is also a partial one: a large share of those assessments showed no meaningful change in the folds.
The lower lid is similar. Supporting the cheek can make the junction between lid and cheek look smoother, but under-eye hollows are a separate area with their own anatomy and risks, and the cheek trials did not measure them.
The candid summary is that cheek filler often produces a modest change that people describe as looking rested. When the main problem is loose skin rather than lost volume, adding filler tends to add weight rather than lift, and the plan should say so.
Which fillers are FDA-approved for the cheek
Every filler is approved for specific areas. Two hyaluronic acid fillers carry an FDA indication for cheek volume:
- Juvéderm Voluma XC. the FDA approved Juvéderm Voluma XC on October 22, 2013 for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21 (source, verified ).
- Restylane Lyft with Lidocaine. the FDA approved Restylane Lyft with Lidocaine on July 1, 2015 for subcutaneous to supraperiosteal implantation for cheek augmentation and correction of age-related midface contour deficiencies in patients over the age of 21 (source, verified ).
Two other products often come up for the midface. Sculptra is poly-L-lactic acid, a biostimulator that prompts the body to build collagen rather than filling space directly: a 2023 FDA approval expanded Sculptra's use to the correction of fine lines and wrinkles in the cheek region in people whose immune response is in the normal range (source, verified ), which is an indication for wrinkles in the cheek rather than for cheek volume. Radiesse is calcium hydroxylapatite: Radiesse's FDA approval, decided December 22, 2006, is for subdermal implantation to correct moderate to severe facial wrinkles and folds such as nasolabial folds, and its approval record does not list a cheek indication (source, verified ).
Using a filler outside its labeled areas is off-label. It is legal and common when the prescriber judges it appropriate, but you should be told which parts of a plan are off-label. One practical difference matters more than the label: hyaluronic acid filler can be dissolved with hyaluronidase, and calcium hydroxylapatite and poly-L-lactic acid cannot.
How long cheek filler lasts
The FDA trials for both approved hyaluronic acid fillers compared treated people with an untreated control group and followed them for months after treatment.
Voluma XC: in the Voluma XC pivotal trial, 85.6% of treated subjects improved by at least one grade on a midface volume scale at month 6, against 38.9% of untreated controls (source, verified ); of the Voluma XC subjects still followed at month 24, 67.1% (112 of 167) remained responders (source, verified ). Restylane Lyft: in the 200-subject Restylane Lyft cheek trial, 88.7% of treated subjects were responders on a midface fullness scale at month 2, against 16.0% of untreated controls (source, verified ); at month 12, 54.3% (75 of 138) of Restylane Lyft subjects were still responders, against 16.3% of untreated controls (source, verified ). Sculptra: in Sculptra's cheek study, patients received up to four injections, and the FDA says the results may last up to 24 months (source, verified ).
Three cautions apply to these figures. First, a “responder” improved by one grade on a rating scale; it does not mean the result looked the same as on day one. Second, they come from trial populations and trial volumes: the median total volume injected in the Voluma XC trial was 6.6 mL (source, verified ), across both cheeks and including touch-ups. That is a trial figure, not a plan for anyone, and the amount for any one person is set only at a consultation. Third, the two products were not compared head to head.
How long filler is visible and how long it is present are different questions. a 2026 review notes MRI studies showing hyaluronic acid filler can remain in the face for up to 27 months, longer than the six months to a year traditionally assumed (source, verified ). That matters for repeat treatment, because adding filler on a schedule, on top of filler that has not gone, is one of the ways a midface becomes overfilled.
How placement works
Cheek filler is placed with the anatomy, not a diagram, in mind. What follows is a plain description of the principles, not instructions.
Depth
Both FDA indications describe deep placement, from under the skin down to the bone. Placing filler directly on the bone, supraperiosteal placement, uses the cheekbone as a foundation and keeps product below many of the vessels that run closer to the surface. A review of facial filler anatomy describes the cheek being treated either with larger volumes in that deep plane or with fanning in a more superficial layer, depending on the goal.
Needle or cannula
A needle reaches a precise point on the bone. A cannula is a blunt-tipped tube threaded under the skin from one entry point. The same review notes that cannulas carry a lower risk of vascular occlusion and needles reach the target depth more directly; both have caused occlusions. The filler safety guide sets out the evidence and its limits.
The vessels in the region
The midface has several arteries close to where filler goes. The facial artery closely follows the fold from the nose to the mouth. the angular artery runs within 5 mm of the nasolabial fold and can take an unusual course in up to 30% of patients (source, verified ). The infraorbital artery and nerve leave the bone through a small opening below the lower rim of the eye socket, and the review advises injecting to the side of it rather than over it. Some of these vessels connect with arteries that supply the eye, which is why the cheek, though not the highest-risk zone, is never treated as a safe one.
The fat compartments of the cheek are also crossed by ligaments. The same review notes that filler placed between them can disturb lymphatic drainage and cause persistent swelling known as malar mounds.
What the visit and aftercare involve
A first visit for a new patient starts with a Good Faith Exam: a medical history and examination by the delegating prescriber Tanya practices under, as Arizona requires, before any treatment is ordered. Whether filler is suitable, which product, where and how much are decided then, not before.
On the day, the face is usually assessed sitting up and in motion, because the cheek changes shape when you smile. The skin is cleaned, and both FDA-approved hyaluronic acid cheek fillers contain lidocaine to reduce discomfort. Filler is placed slowly in small amounts, with the skin watched for color change throughout.
Afterwards, expect tenderness, swelling and some firmness. in the Voluma XC trial, 98% of subjects reported a local treatment site response such as tenderness, swelling or firmness, mostly moderate and lasting 2 to 4 weeks; for moderate or severe responses the median time to complete resolution was 6 days (source, verified ). in the Restylane Lyft cheek trial, local reactions such as swelling, bruising and pain resolved in a median of 11 days (source, verified ). the Voluma XC labeling asks patients to avoid strenuous exercise and extensive sun or heat exposure for the first 24 hours, and allows a short application of an ice pack if the area is swollen (source, verified ). A review visit after swelling has settled is the fair point to judge the result.
Risks specific to the cheek
Swelling, bruising and lumps
These are expected, and usually settle over days to weeks. Lumps that can be felt early are often filler that has not yet settled. in the Voluma XC trial, device-related adverse events were significantly more frequent with larger injection volumes and in older subjects, and injection volume correlated with swelling and bruising (source, verified ), which is one reason a conservative first treatment is sensible. Later lumps are uncommon: 2 of 270 treated subjects (0.7%) in the Voluma XC trial had serious device-related events, inflammation or lumps in the cheek or under the eye about 6 to 7 months after treatment, and all resolved with treatment that included hyaluronidase (source, verified ).
Asymmetry
Faces are not symmetrical before treatment, and swelling settles unevenly afterwards. Judge symmetry after swelling has gone down, not the next morning.
Overfilling and the “pillow” look
The review of facial overfilling cited above describes facial overfilled syndrome as an overly inflated look with unnatural volume in the midface, often most obvious on smiling, and lists “pillow face” among its features. It attributes it to more volume than the tissue can hold, filler placed at the wrong depth, assessment done only at rest, and filler accumulating over repeated treatments. Hyaluronic acid filler can be dissolved; other materials cannot.
Migration
Filler can move from where it was placed. In the cheek that can mean fullness drifting toward the lower lid. Filler migration is uncommon and, for hyaluronic acid, can be dissolved.
Vascular occlusion
The rare serious risk is filler in or pressing on an artery. Restylane Lyft labeling states that vascular occlusion, with tissue damage or vision disturbance including blindness, has been reported after injection of any soft tissue filler in the face, especially the nose, glabella, periorbital areas, nasolabial folds and cheek, with onset from immediate to a few weeks after injection (source, verified ). Warning signs include pain out of proportion, skin that turns white, dusky or mottled, and any change in vision. What a vascular occlusion is, and what the warning signs are explains what to watch for and how it is treated.
Who should not have cheek filler, or should wait
The FDA advises delaying filler while there is active skin inflammation or infection in the area, and lists bleeding disorders, severe allergies or a history of anaphylaxis, and allergy to components such as lidocaine as reasons for caution or exclusion. the FDA says the safety of dermal fillers is unknown in people who are pregnant or breastfeeding and in people under 22 (source, verified ). the Voluma XC labeling published at its 2013 approval states that safety in patients under 35 or over 65 years has not been established (source, verified ). Sculptra is not used in people prone to keloids or raised scars.
Blood-thinning medicines and supplements raise the chance of bruising, and a cold sore history, recent dental work, autoimmune conditions and previous filler or surgery in the area all change the plan. These are covered at the Good Faith Exam. Someone whose main concern is loose skin, or who already has filler in the cheeks, may be better served by a different plan or by none.
Questions to ask at a consultation
The FDA suggests asking about the injector’s training and experience, asking for the patient labeling of the specific filler, and asking how a blood vessel injection would be handled. For the cheek, add these:
- Which product is proposed, and is it FDA-approved for the cheek or used off-label here?
- Can it be dissolved if I do not like it, or if something goes wrong?
- How much will be placed today, and will we review before adding more?
- Is there filler already in my face, and how does that change the plan?
- What should I do, and whom do I call, if I notice pain, color change or a change in vision afterwards?
A clear answer to each, before any treatment, is part of a careful consultation. Tanya’s approach to planning is described on the dermal fillers page, and how complications are prepared for on the safety page.
Sources
- Summary of Safety and Effectiveness Data, Juvéderm Voluma XC (P110033) , U.S. Food and Drug Administration Regulator Accessed
- Juvéderm Voluma XC labeling at original approval (P110033) , U.S. Food and Drug Administration Regulator Accessed
- Summary of Safety and Effectiveness Data, Restylane Lyft with Lidocaine, cheek and midface indication (P040024/S073) , U.S. Food and Drug Administration Regulator Accessed
- Summary of Safety and Effectiveness Data, Restylane Lyft with Lidocaine (P040024/S142) , U.S. Food and Drug Administration Regulator Accessed
- Sculptra – P030050/S039 , U.S. Food and Drug Administration Regulator Accessed
- Premarket Approval database, Radiesse Injectable Implant (P050052) , U.S. Food and Drug Administration Regulator Accessed
- Dermal Fillers (Soft Tissue Fillers) , U.S. Food and Drug Administration Regulator Accessed
- Facial fillers: Relevant anatomy, injection techniques, and complications , World Journal of Otorhinolaryngology - Head and Neck Surgery (PubMed Central) Peer-reviewed Accessed
- Facial Overfilled Syndrome: A Narrative Clinical Review , Clinical, Cosmetic and Investigational Dermatology (Dove Medical Press) Peer-reviewed Accessed
Questions readers ask
Does cheek filler lift sagging skin?
Not in the way surgery does. Filler adds volume and support under the skin, which can soften the shadows that sagging creates, but it does not remove or tighten loose skin. When laxity is the main problem, more filler tends to add weight rather than lift, and that is a reason to talk about other options.
Will people be able to tell I have had it?
A conservative midface treatment is usually read as looking rested rather than treated. What makes filler noticeable is volume out of proportion to the face, especially when it shows as a bulge on smiling. Asking to see the plan in a mirror, while you animate, helps keep the result in proportion.
Can cheek filler be done in one visit?
Often the plan includes a first treatment and a review once swelling has settled, when a small top-up may or may not be needed. Both FDA trials for hyaluronic acid cheek fillers allowed a touch-up after the first session. Sculptra works differently and is given as a series.
Is it normal for one cheek to look bigger the next day?
Some unevenness in the first days is common, because swelling and bruising rarely settle at the same speed on both sides. Judge symmetry once the swelling has gone down. A side that is painful, pale, dusky or mottled is different, and needs a call the same day, whatever the hour.
What happens if I do not like the result?
A hyaluronic acid filler can be dissolved with the enzyme hyaluronidase, in part or in full, after an assessment. Fillers made of other materials, such as calcium hydroxylapatite or poly-L-lactic acid, cannot be dissolved this way, which is worth weighing before a first treatment.
Revision history (1)
- update First version, written from FDA labeling and peer-reviewed literature Editorial team